EVALUATION OF OINTMENT ACTIVITY BASED ON TERMINALIA MANTALY EXTRACT
Abstract
In Côte d’Ivoire pharmacopoeia the antifungal virtues of the bark of Terminalia mantaly are known. It bark is used to cure affections such as cutaneous candidiasis, gingivitis and diarrhoea. This work aims to compare the anticandidosic activities of the crude extract of T. mantaly and an ointment containing shea butter and the crude extract of T. mantaly. The anticandidosic activity of the crude Shea butter was also evaluated and kétoconazole was used as standards for antifungal assay.
Shea butter, kétoconazole, crude extract of T. mantaly and the ointment were separately incorporated to Sabouraud agar using the agar slanted double dilution method. The anti-fungal tests were performed by sowing 1000 cells of Candida albicans on a previously prepared medium culture. Antifungal activity was determined by evaluating of anti-fungal parameters values (minimal fungicidal concentrations MFC and IC50).
The results of the tests indicate that C. albicans is sensitive to each substance tested, however crude Shea butter has only fungistatic activity and the ointment (MFC= 1.874µg/mL) was the most active. This ointment is 52 times more active than the crude extract of T mantaly (MFC is of 97.5 µg/mL), 208.11 more active than kétoconazole (MFC = 390 µg/mL).
Keywords: Terminalia mantaly, Activity, ointmentDOI
https://doi.org/10.22270/jddt.v6i5.1314References
Dromer F., Lortholary O., Bretagne S., Garcia-Hermoso D., Desnos-Ollivier M., Sitbon K., Renaudat C., Blanc C. & Hoinard D. Centre National de Référence Mycoses Invasives et Antifongiques. Rapport annuel d’activité. Réseaux Instituts Pasteur France. 2013, 49 p
Assob J.C.N. And Nsagha D.S. African medicinal plant derived products as therapeutic arsenals against multidrug resistant microorganisms. J. Pharmacog. Phytother. 2014; 6:59-69
Hitchkock C.A. Resistance of Candida albicans to azole antifungal agents. Biochem. Soc. Trans. 1993; Vol. 21, 1039-1047pp.
Chabasse D. Les champignons opportunistes Nouveaux apparus en médecine. Revue générale.J MÃ © Mycol d. 1994;4: 9-28.
Chabasse D, Pilet M, Bouchara J.P. Emergence de Nouveaux champignons Pathogènes en médecine. Rev francoph Lab. 2009; 71-86.
Akakpo-Akue J.M., formulation dune crème à base de l’huile de MISCA, DEA Biotech. Pharma. S.N., UFR Biosciences Univ. Abidjan, 2006, 29p
Attoh- Toure H., Ekra K.D., Tiembre I., Coulibaly A., Aka L.N., Douba A., Ouhon J, Assoumou A. Etude de la flore fongique dermatophytique de l’hôpital général Felix Houphouët-Boigny D’abobo (Abidjan) J. sci. pharm. biol., 2009 ; 10(1) :64-71.
Vanden B. H. Mechanisms of antifungal resistance. Rev. Iberoam. Micol. 1997; Vol. 14, 44-49pp.
Sanglard D., Ischer F., Calabrese D., De Micheli M. And Bille J. Multiple resistance mechanisms to azole antifungals in yeast clinical isolates. Drug Res. Updates. 1998; Vol. 1, 255-265pp.
Freiman A. Et Sasseville D. Les médicaments antifongiques en dermatologie. Dermatologie. Conférences Scientifiques. Division de dermatologie, Centre Universitaire de Santé. Mc GILL. 2006 ; 6 p.
Ake -Assi. L Et Guindo S. (1991). Plantes utilisées dans la médecine traditionnelle en Afrique de l’Ouest. Éd : Roche.151p
Cowan M.M. (1999). Plant product as antimicrobial agents. Clin. Microbiol. Rev. 12:564-582p.
Hostettmann K. And Marston, A. Twenty years of research into medicinal plants: results and perspectives. Phytochem. Rev. 2002; Vol. 1, 275-285.
Aladesanmi A. J., Iwalawa E. O., Adebajo A. G., Akinkunmi E. O., Taiwo B. J., Antimicrobial and antioxidant activities of some Nigeria medicinal plants Afr. J. Tradit. CAM. 4(2): 173-184pp.la date?
Nkomo M., Kambizi. Antimicrobial Activity of gunnera perpensa and heteromorpha arborenscens var.abyssinica J. Med. Plants Res. 2009; 3(12):1051-1055.
Kuete V., Tabopda T.K, Ngameni B., Nana F., Tshikalange Te, Ngadjui B.T. Antimycobacterial, antibacterial and antifungal activities of Terminalia superba (Combretaceae). South African Journal of Botany. 2010; 76:125-131.
Ahon G. M., Kra A.K.M., Aw S., Zirihi G. N., Ackah J.A.A. B., Siaka S., Kporou K. E., Akakpo-Akue M. J. And Djaman A. J.. Improvement of the antifungal activity of the hydro-alcoholic extract of Terminalia superba on the in vitro growth of three pathogenic fungi. Inter. J. Biol. Pharma. Al. Sci. (IJBPAS). 2012; Vol. 1, 1434-1442pp.
Kra A.K.M., Siaka S., Ahon GM; Kassi A.B.B., Ouattara S., AW Sadat, Coulibaly A., Soro Y., And Djaman A.J. Antifungal Activity Of Terminalia Superba (Combretacée) Journal of Experimental Biology and Agricultural Sciences, April - 2015; 3(2):162-173
Zirihi G.N. Contribution au recensement, a l’'identification et à la connaissance de quelques espèces végétale traditionnelles utilisées en medecine traditionnelle chez les Bétés du département d’Issia. Thèse de doctorat de Doctorat 3ème Cycle de Botanique, FAST. Abidjan. Côte d’Ivoire: Université Cocody; 1991. p. 253.
Riviere C., Nicolas J.-P., Caradec M.-L., Desire O. Et Schmitt A. Les plantes de la région Nord de Madagascar : une approche ethno pharmacologique. Bull. Soc. Fr. Ethnopharmacol. & Soc. Eur. Ethnopharmacol. 2005; 36:36-49.
Yaye Y. G., Ackah J.A.A.B., Kra A. K. M. And Djaman A.J. Antifungal activity of different extracts of Terminalia mantaly H. Perrier on the in vitro growth of Aspergillus fumigatus. Europ. J. Sci. Res. 2012; Vol. 82, 132-138pp.
Yayé Y. G., Kra A K M, ACKAH J.A.A.B et DJAMAN A.J. « Evaluation de l’activité antifongique et essai de purification des principes actifs ses extraits de Terminalia mantaly (H.Perrier), Une combrétacée, sur la croissance in vitro de Candida albicans» Bulletin de la Société Royale des Sciences de Liège, 2011; V 80, 2011, p. 953 – 964
Ackah J.A.A.B., Yaye Y.G., Yapi H.F., Kra A.K.M., and Djaman A.J. Antifungal Activity of Terminalia mantaly on the in vitro Growth of Cryptococcus neoformans International Journal of Biochemistry Research & Review, 2013; 3(1):63-73.
Kra Adou Koffi Mathieu, Ahon Gnamien Marcel, Djo-Bi Djè, Ouattara Sitapha, Coulibaly Adama, Djaman Allico Joseph (2014) Antifungal activities of medicinal plants extracts of Ivorian pharmacopoeia Journal of Intercultural Ethnopharmacology; 159-166
Zirihi G Nl, Koffi N, Kassy N J, Coulibaly Ka Djaman A.J. L'évaluation de la Comparaison et des activités antifongiques de Terminalia Catappa et Terminalia Mantaly (combretacial) in vitro sur la croissance d'Aspergillu fumigatus. Journal of Plantes médicinales recherche, 2011; 6(12) :2299-2308.
Ajello L.; Georg L.K.; Kaplan W. & Kaufman L., 1963. Laboratory manual for medical mycology. 2nd. Ed. JOHN WILEY and Sons, Inc. New- York
Holt R. J. Laboratory test of antifungal drugs. J. Clin. Path., 1975; 18 :767- 774
Zirihi. N.G. & Kra A.K.M.,. Evaluation de l'activité antifongique de Microglossa pyrifolia (LARMARCK) O. KUNTZE (Asteraceae) "PYMI" sur la croissance in vitro de Candida albicans. Rev Méd. et Pharm. Afric., 2003; Vol. 17, 11–19
ACKAH J.B.A.. Spectre anti-infectieux de MISCA-F3 sur la croissance in vitro Candida albicans, Trichophyton mentagrophytes, Trichophyton rubrum, Cryptococcus neoformans, Aspergillus fumigatus et Aspergillus flavus. Mémoire DEA. Biotechnologie, Université de Cocody, Abidjan. Côte d’Ivoire. 32pp.30Teas, 2008
Hussain N, Kakoti BB, Review on ethnobotany and phytopharmacology of cordia dichotoma, Journal of Drug Delivery and Therapeutics, 2013; 3(1) :110-113
Kporou KE, Kra AK, Ouattara S, Guédé-Guina F. Evaluation de la sensibilité de Candida albicans aux extraits de Mitracarpus scaber une rubiaceae codifiée MISCA. Bull Soc Roy Sci Liège; 2009; 78: 12-23.
OUATTARA S., KPOROU K.E, KRA A.K.M. YAPI H. Optimisation de l' in vitro une activité antifongique de l'extrait hydroalcoolique de Treminalia ivoriensis A. Chev. J Nat Prod Resour usine. 2013; 4: 29-33.
ROBERT RAOUL. (1983). Technique professionnelle et documents pharmaceutiques : à l'usage des préparateurs en pharmacie, du personnel de la pharmacie hospitalière, des stagiaires et étudiants en pharmacie, des moniteurs de cours et des pharmaciens Ed. Broché
Mathieu M-J, Fonteneau J-M. (2008). Le manuel porphyre du préparateur en pharmacie: préparation du BP, formation. Collection porphyre, Ed. Wolters Kluwer France, - 1177-1410pp.
Klusiewicz P., Fonteneau J-M (2008). Cahier de préparation en pharmacie -Travaux pratiques de préparation et de conditionnement des médicaments page 85-87.Collection porphyre, Ed. Wolters Kluwer France, 7 fev. - 281 p
Charpentier B., Hamon-Lorleac'h F., Harlay A., Ridoux L. (2008).: Guide du préparateur en pharmacie, Ed. Elsevier Masson, - 1358 p
Mautrait C, Raoult R. (2009). La préparation (mode d'emploi) ; Ed. Wolters Kluwer France, 468 p
Boutet J.P. (1967). Le diméthylsulfoxyde (DMSO) de la pétrochimie à la pharmacie. Thèse Doct, vétér. École nationale vétérinaire. Toulouse.
Bean G. A., Rambo G. W., Klarman W. L. Influence of dimethylsulfoxyde (DMSO) on conidial pigmentation and consequent UV light sensitivity of aflatoxin producing strains of Aspergillus flavus. Life Sci., 1969 ; 8, 1185-1191
Sanogo R, Konipo A, Maiga Arama A, Diallo D, Bougoudogo F. Formulation d'une pommade dermiqlœ à base d'extraits de mitracarpus SCABER (ZUCC) Pharm. Méd. Trad. Afr. 2006, Vol. XlV. pp. 159-177
Baba-Moussa F, Akpagana K, Bouchet P. Activités antifongiques de sept Combretaceae Afrique de l'Ouest utilisée en médecine traditionnelle. J. Ethnopharmacol, 1999; 66: 335-338.
Zeidan R, Oran S, Khleifat K, Matar S. Antimicrobial activity of leaf and fruit extracts of Jordanian Rubus sanguineus Friv. (Rosaceae). African Journal of Microobiology Research. 2013; 7: 5114-5118µ.
Majgaine P., Verma D.L. Antifungal Activity Of Olea Cuspidata And Olea Gladulifera Linn; Journal Of Pharmacy Volume, 2013; 3, 5, Pp 20-23
Ackah JA, Kra AK, Zirihi GN, Guédé-Guina F. Evaluation et essais d’optimisations de l’activité anticandidosique de Terminalia catappa Linn. (TEKAM3), un extrait de combretacée de la pharmacopée Ivoirienne. Bull Soc Roy Sci Liège; 2008, 77:120-36
Published


How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).